ESTRO乳腺癌术前放疗推荐:现状与未来展望
欧洲放射肿瘤学会(ESTRO)乳腺专家组基于27项I/II期研究,系统综述了术前放疗在低复发风险早期乳腺癌、高复发风险乳腺癌及需乳房切除术患者中的应用现状与证据缺口;因缺乏足够临床数据制定正式指南,专家组以 perspective 形式提出未来研究方向与试验建议。
要点
- 术前放疗在乳腺癌中非新概念,但现有数据不足以转化为临床实践。
- 综述纳入2000年以来27项I/II期研究,涵盖剂量分割、临床结局与并发症率。
- 因证据不足未形成正式指南,专家组提出未来临床试验与研究项目方向。
核心结论
- 当前临床数据不足以支持制定术前放疗的正式指南,专家组以 perspective 形式提出未来研究方向,以推动高质量、改变实践的数据产生。
研究设计与样本
- ESTRO乳腺亚组提案经ESTRO指南委员会批准,成立专家组并分设四个工作组,分别聚焦低复发风险早期乳腺癌、高复发风险乳腺癌、需乳房切除术患者及交叉主题(临床前与转化、放射生物学、放疗技术与质量保证)。
- 经文献检索识别关键点与证据缺口后,各工作组汇报发现,专家组讨论并批准形成 perspectives。
主要发现
- 共纳入2000年以来27项I期和II期研究,收集放疗剂量与分割、临床结局及并发症率等数据。
- 专家组基于现有证据与知识缺口,针对不同临床场景提出 perspectives,供未来临床研究解决。
临床怎么用
- 现有证据尚不支持将术前放疗常规用于临床实践,需通过未来临床试验与研究项目进一步验证。
局限性
- 现有临床数据不足以制定正式指南,本文以专家组 perspectives 形式呈现而非推荐条款。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Preoperative radiation therapy (RT) for breast cancer is not a novel concept, though available data are insufficient to translate current knowledge into clinical practice. Nonetheless, potential advantages of this approach are emerging in multiple scenarios, incorporating increasing treatment personalization and technological improvements in RT. This paper aims to synthesize and summarize the literature on preoperative RT in distinct breast cancer treatment settings, providing perspectives based on existing evidence and gaps in knowledge. METHODS: The ESTRO Breast subgroup proposal for elaborating perspectives on preoperative RT was approved by the ESTRO Guidelines Committee, and a panel of experts in the field was identified. Four working groups were created, focusing on the different clinical settings where preoperative RT has been investigated: patients with early-stage breast cancer at low risk of recurrence, patients with breast cancer at high risk of recurrence, and patients with an indication for mastectomy. The fourth group focused its search on cross cutting themes, such as preclinical and translational aspects, radiobiology, RT techniques and quality assurance. After a literature search including the identification of key points and gaps in the literature, the four working groups presented their findings and perspectives were formulated, discussed and approved by the panel. RESULTS: Overall, 27 phase I and phase II studies enrolling patients from the year 2000 onward were considered, collecting data such as RT dose and fractionation, clinical outcomes, and complications rates. The expert panel stated perspectives for the different clinical scenarios based on available evidence and current gaps in knowledge, to be addressed by future clinical research. CONCLUSION: Given the current lack of clinical data to support the development of formal guidelines, we present our perspectives, which can be useful for implementing new clinical trials and research projects, overcoming current limitations, and potentially generating high-quality practice-changing data, introducing preoperative RT in specific breast cancer treatment settings in the future.
引用
- Zamagni A, Montero Luis A, Mjaaland I, et al. ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives - Endorsed by ASTRO. Radiother Oncol. 2025. PMID: 41161390. doi:10.1016/j.radonc.2025.111236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。